During the recent session, Accelerate Diagnostics Inc (NASDAQ:AXDX)’s traded shares were 1.34 million, with the beta value of the company hitting 0.27. At the last check today, the stock’s price was $0.17, reflecting an intraday loss of -64.32% or -$0.3. The 52-week high for the AXDX share is $2.09, that puts it down -1129.41 from that peak though still a striking -164.71% loss since the share price plummeted to a 52-week low of $0.45. The company’s market capitalization is $4.19M, and the average trade volume was 41.93K shares over the past three months.

Accelerate Diagnostics Inc (AXDX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. AXDX has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.

Accelerate Diagnostics Inc (NASDAQ:AXDX) trade information

Accelerate Diagnostics Inc (AXDX) registered a -64.32% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -64.32% in intraday trading to $0.17, hitting a weekly high. The stock’s 5-day price performance is -67.39%, and it has moved by -71.34% in 30 days. Based on these gigs, the overall price performance for the year is -81.92%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 32.62%.

AXDX Dividends

Accelerate Diagnostics Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of Accelerate Diagnostics Inc (AXDX) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 381.46 shares. This amounts to just over 1.51 percent of the company’s overall shares, with a $55501.0 market value. The same data shows that the other fund manager holds slightly less at 95.33, or about 0.38% of the stock, which is worth about $13870.0.